Mr Mrs Miss Ms Dr Other

Dr
Thomas
Olbrich

Patent Director

Newcastle Office

Engineering

Telephone. +44(0) 191 205 8360
Mobile. +44(0) 771 744 0324
Email. [email protected]

Experience

Tom is a PHD physicist with a real passion for most technologies and innovation. Tom's extensive experience covers a wide spectrum of technologies, from relatively simple concepts, such as shoes, floating platforms and power tools, to semiconductor and superconductor systems, as well as, computer implemented applications and medical devices. Tom has considerable experience (15+ years) in patent drafting and European, as well as worldwide patent prosecution.

Tom's areas of expertise include engineering, electronics and physics related technology in general, and in particular, medical devices, sporting goods, semiconductors and ICs, power tools, automotive fasteners, appliances, as well as, offshore and oil & gas technology (e.g. downhole tools, seismic interpretation software).

After spending a few years in the special military forces in his native Germany, competing i.a. in athletics, biathlon and bobsleigh, Tom went to study Applied Physics (MSc) at the University of Applied Science in Munich and Physics (BSc) at Nottingham Trent University. In order to further his studies, he then completed a PhD in Medical Physics at the University of Newcastle upon Tyne.

In 2005, he began working towards becoming a Patent and Trade Mark attorney. He has since gained extensive experience working with four leading European patent firms. He is known for a very personal approach and a high quality of work.

Qualifications

Patent Attorney

Europe


BSC

Physics

MSC

Applied Physics

PHD

Medical Physics

Publications

Northern Insight Article

View publication online

CSR

Tom is involved with mentoring Trainees in patent drafting.

Related News

New Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Investing in Patents for Space Tech: Safeguarding Innovations in the Space Sector

The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …

Read article

End of EPO "10 day rule" from 1 November 2023 – 4 weeks to go

Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them.   This means that communications are deemed to …

Read article
Event - 21st, 28th November 2023

Dresden & Salzburg Seminar: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …

Event details
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Event details

AI-Powered Personalised Medicine

The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.